Loading company
Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Vertex Pharmaceuticals Inc. / MA and every other company we cover.
Try it first on NVDA, AAPL, META or NKE, where it is open to everyone.
VRTX · Nasdaq · Healthcare · Biotechnology
Next earnings: November 2, 2026
$526.19+0.7%Sep 25 close
Vertex develops and sells medicines for cystic fibrosis, inherited blood disorders, acute pain, and other serious diseases.